GFS Advisors »

Recursion Pharmaceuticals shares owned by GFS Advisors

Quarter-by-quarter ownership of Recursion Pharmaceuticals (RXRX) shares owned by GFS Advisors from 13F filings

Historical chart of GFS Advisors investment in Recursion Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Recursion Pharmaceuticals held by GFS Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Recursion Pharmaceuticals by GFS Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $15k 10k 1.47

More positions owned by GFS Advisors

Cardinal Health (CAH)
Byline Ban (BY)
HEICO Corporation (HEI)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Spdr Series Trust St Str Sp500div (SPYD)
United Parcel Svcs CL B (UPS)
Tesla Motors (TSLA)
Ishares Tr Msci Eafe Etf (EFA)
Ishares Tr Msci Acwi Etf (ACWI)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ecopetrol S A Sponsored Ads (EC)
Walt Disney Company (DIS)

View all positions for GFS Advisors

Top funds holding Recursion Pharmaceuticals

BlackRock
ARK Investment Management
Vanguard Portfolio Management
State Street Corporation
Baillie Gifford & Co
Vanguard Capital Management
Geode Capital Management
Softbank Group Corp
MIC Capital Management UK
UBS Group
Susquehanna International
Norges Bank Investment Management
Data Collective IV GP
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas

View all funds holding Recursion Pharmaceuticals